FDA 483 - LTS Therapy Systems, LLC - September 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of LTS Therapy Systems LLC in Saint Paul, MN, a drug manufacturer, revealed significant deficiencies across multiple quality system areas. The firm failed to thoroughly investigate manufacturing discrepancies, maintain adequate laboratory controls including data integrity, and establish sound production and process control procedures. Additionally, the quality control unit's responsibilities and procedures were found to be inadequate, indicating a broad lack of adherence to cGMP requirements.
ID · 37b54d1f-ed22-42ec-a7d6-ad9fa71abc23